RAC 6.80% $1.89 race oncology ltd

Industry news, page-1182

  1. 1,103 Posts.
    lightbulb Created with Sketch. 106
    I’m excited by the direction the new CEO is taking. He’s obviously identified all the elements that are needed to push forward, developed this role, and is moving quickly to take Race to the next level. It will be great to get another newcomer to the organisation to support this.
    Daniel did the hard yards inmoving the organisation from a penny dreadful to a leader in the science around Zantrene. It’s highly appropriate for the new CEO to move to the next level of scientific and commercial collaboration. And he seems to be doing this enthusiastically and quickly.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.